Oncology Informatics: Status Quo and Outlook.
Oncology Informatics: Status Quo and Outlook.
复制标题
作者：
Putora PM;Baudis M;Beadle BM;El Naqa I;Giordano FA;Nicolay NH
肿瘤学取得了快速发展，在癌症干细胞、分子靶向治疗、基因组分析和个性化免疫治疗等领域出现了新的发展。这些进展扩大了抗击癌症的可用工具。其中一些事件得到了媒体的广泛报道，引起了理所当然的公众关注。然而，这些成就只能归功于不断扩大的生物医学信息学和信息技术(IT)领域的快速发展。人工智能、放射组学、电子健康记录和电子患者报告结果测量(EPROM)只是使肿瘤学进一步取得进展的少数几项发展。IT在肿瘤学中的良好影响只有通过多学科的方法来应对未来的复杂挑战才能成为现实。
Oncology has undergone rapid progress, with emerging developments in areas including cancer stem cells, molecularly targeted therapy, genomic analysis, and individually tailored immunotherapy. These advances have expanded the tools available in the fight against cancer. Some of these have seen broad media coverage resulting in justified public attention. However, these achievements have only been possible due to rapid developments in the expanding field of biomedical informatics and information technology (IT). Artificial intelligence, radiomics, electronic health records, and electronic patient-reported outcome measures (ePROMS) are only a few of the developments enabling further progress in oncology. The promising impact of IT in oncology will only become reality through a multidisciplinary approach to the complex challenges ahead.
登录
查看更多内容
影响因子：
5
作者：
El Shafie RA;Weber D;Bougatf N;Sprave T;Oetzel D;Huber PE;Debus J;Nicolay NH
通讯作者：
Nicolay NH
影响因子：
5
作者：
Kessel KA;Vogel MM;Alles A;Dobiasch S;Fischer H;Combs SE
通讯作者：
Combs SE
影响因子：
64.8
作者：
Esteva A;Kuprel B;Novoa RA;Ko J;Swetter SM;Blau HM;Thrun S
通讯作者：
Thrun S
影响因子：
4.6
作者：
Shen, Li;Margolies, Laurie R.;Sieh, Weiva
通讯作者：
Sieh, Weiva
DOI：
10.1259/bjro.20190021
发表时间：
2019
期刊：
BJR open
影响因子：
--
作者：
Luo Y;Tseng HH;Cui S;Wei L;Ten Haken RK;El Naqa I
通讯作者：
El Naqa I